Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canntab Therapeutics Limited C.TFS

"Canntab Therapeutics Ltd is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the research and development of advanced pharmaceutical grade formulations of cannabinoids. It has developed in-house technology to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical dosages for therapeutic use."


CSE:TFS - Post by User

Post by Greenhemp2018on Jan 14, 2018 9:18pm
229 Views
Post# 27355516

TFS stick consolidation - clarification

TFS stick consolidation - clarificationFolks, do not read the LOi as those numebrs are not directly relates to the actual stock  price.  Here is the answer a friend on the forum receiced directly from tfs:

<snip>
1. TFS shares will consolidate 200 to 1. So if the share price is 0.07 cents when it consolidates, you'll own 1 share worth $14.

2. Telferscot Resources will buy out Canntab shares at a rate of 4 TFS shares to 1 Canntab share. This has NOTHING to do with our TFS shares. It's how Telferscot is acquiring Canntab. Here, 1.6.1 is most likely correct about Canntab wanting to use TFS to go public. Read his/her post.

3. Canntab will raise $5 million by issuing 1,250,000 of their own shares much like a PP (possibly even a PP). The $4 price is set to attract investors and does not reflect the actual share price. It's usually set lower so investors will earn their money back. Again, this has nothing to do with our TFS shares but a condition of acquiring Canntab.

4. The 24.4 million shares resulting is a combination of the existing TFS shares (consolidated 200:1) and the acquired Canntab shares.

<snip>
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse